AXIM BIOTECHNOLOGIES, INC. Repayments of Convertible Debt
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Repayments of Convertible Debt of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2024-04-16
- AXIM BIOTECHNOLOGIES, INC. repayments of convertible debt for the quarter ending 2022-12-31 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. repayments of convertible debt for the quarter ending 2022-09-30 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. repayments of convertible debt for the quarter ending 2022-06-30 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. repayments of convertible debt for the quarter ending 2022-03-31 was $1.24M.
- AXIM BIOTECHNOLOGIES, INC. repayments of convertible debt for fiscal 2022 was $1.24M.
- AXIM BIOTECHNOLOGIES, INC. repayments of convertible debt for fiscal 2019 was $7.50K, a 99.62% decline from fiscal 2018.
- AXIM BIOTECHNOLOGIES, INC. repayments of convertible debt for fiscal 2018 was $1.97M.
- AXIM BIOTECHNOLOGIES, INC. repayments of convertible debt for fiscal 2017 was $0.00.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-20 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $0.00 derived: sum of 2 quarters · filed 2024-04-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | $1.24M 10-K · filed 2024-04-16 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $0.00 derived: sum of 2 quarters · filed 2023-11-20 | $1.24M 10-Q · filed 2023-11-20 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $1.24M 10-Q · filed 2023-08-21 | ||
| 2022-03-31 | $1.24M 10-Q · filed 2022-05-23 | |||
| 2021-09-30 | $0.00 10-Q/A · filed 2022-11-15 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-23 | |||
| 2020-09-30 | $0.00 10-Q/A · filed 2020-11-27 | |||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2020-05-20 | $7.50K derived: sum of 2 quarters · filed 2020-11-27 | $7.50K derived: sum of 3 quarters · filed 2020-11-27 | $7.50K 10-K/A · filed 2020-05-20 |
| 2019-09-30 | $7.50K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-27 | $7.50K derived: sum of 2 quarters · filed 2020-11-27 | $7.50K 10-Q/A · filed 2020-11-27 | $7.50K derived: sum of 4 quarters · filed 2020-11-27 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | $1.00 derived: sum of 3 quarters · filed 2020-05-20 | $782.04K derived: sum of 4 quarters · filed 2020-05-20 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 | $1.00 derived: sum of 2 quarters · filed 2020-05-20 | $782.04K derived: sum of 3 quarters · filed 2020-05-20 | $1.80M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-12-31 | $1.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-05-20 | $782.04K derived: sum of 2 quarters · filed 2020-05-20 | $1.80M derived: sum of 3 quarters · filed 2020-05-20 | $1.97M 10-K/A · filed 2020-05-20 |
| 2018-09-30 | $782.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.80M derived: sum of 2 quarters · filed 2019-11-14 | $1.97M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $1.18M 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $168.89K 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-04-08 |